Evolus, Inc. - Resources - Clinical Publications

Jeuveau^® Clinical Publications

Comparison of Botulinum Toxin A Formulations for Glabellar Strain Treatment in Women - A Double-Blind Randomized Clinical Trial

JAMA Dermatology, 2025

Botulinum Toxin Accessory Proteins: Are They Just an Accessory?

(Dermatologic Surgery, 2024)

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

(Aesthetic Surgery Journal, 2021)

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

(Aesthetic Surgery Journal, 2021)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data

(Aesthetics Surgery Journal, 2022)

PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data

(Dermatologic Surgery, 2021)

PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data

(Dermatologic Surgery, 2022)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

(Dermatologic Surgery, 2019)

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies

(Dermatologic Surgery, 2019)

Evolysse^™ Clinical Publications

Long-term Safety and Effectiveness of Cold-Crosslinked Hyaluronic Acid Fillers: Multicenter, Randomized, Controlled, Double-Blind Study

Aesthetic Surgery, 2025